You have selected the view in English
Descriptor English: | Ceftizoxime | ||||||
Descriptor Spanish: |
Ceftizoxima
| ||||||
Descriptor Portuguese: | Ceftizoxima | ||||||
Descriptor French: | Ceftizoxime | ||||||
Entry term(s): |
Cefizox Ceftizoxime Monosodium Salt Ceftizoxime Sodium FK 749 FK-749 FK749 FR 13749 FR-13749 FR13749 Monosodium Salt, Ceftizoxime SK&F 88373 2 SK&F 88373-2 SK&F 883732 SKF 88373 SKF-88373 SKF88373 Salt, Ceftizoxime Monosodium Sodium, Ceftizoxime |
||||||
Tree number(s): |
D02.065.589.099.249.190.190.145 D02.886.665.074.190.190.145 D03.633.100.300.249.190.190.145 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015296 | ||||||
Scope note: | A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Anti-Bacterial Agents |
||||||
Registry Number: | C43C467DPE | ||||||
CAS Type 1 Name: | 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))- | ||||||
Previous Indexing: |
Cefotaxime/analogs & derivatives (1982-1988) Cephalosporins (1979-1981) |
||||||
Public MeSH Note: | 89 |
||||||
History Note: | 89 |
||||||
DeCS ID: | 23579 | ||||||
Unique ID: | D015296 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1989/01/01 | ||||||
Date of Entry: | 1988/05/24 | ||||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Ceftizoxime
- Preferred
Ceftizoxime Sodium
- Narrower
SKF-88373
- Narrower
FR-13749
- Narrower
SK&F 88373-2
- Narrower
Cefizox
- Narrower
FK749
- Narrower
Concept UI |
M0023550 |
Scope note | A semisynthetic cephalosporin antibiotic which can be administered intravenously or by suppository. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative organisms. It has few side effects and is reported to be safe and effective in aged patients and in patients with hematologic disorders. |
Preferred term | Ceftizoxime |
Concept UI |
M0351052 |
Preferred term | Ceftizoxime Sodium |
Entry term(s) |
Ceftizoxime Monosodium Salt Monosodium Salt, Ceftizoxime Salt, Ceftizoxime Monosodium Sodium, Ceftizoxime |
Concept UI |
M0023554 |
Preferred term | SKF-88373 |
Entry term(s) |
SKF 88373 SKF88373 |
Concept UI |
M0023552 |
Preferred term | FR-13749 |
Entry term(s) |
FR 13749 FR13749 |
Concept UI |
M0023553 |
Preferred term | SK&F 88373-2 |
Entry term(s) |
SK&F 88373 2 SK&F 883732 |
Concept UI |
M0023555 |
Preferred term | Cefizox |
Concept UI |
M0023551 |
Preferred term | FK749 |
Entry term(s) |
FK 749 FK-749 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey